Detalhe da pesquisa
1.
A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
Am J Gastroenterol
; 110(5): 741-8, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25869393
2.
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Gastroenterology
; 140(2): 425-434.e1; quiz e13-4, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21070781
3.
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
J Crohns Colitis
; 10(8): 925-33, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26908939
4.
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial.
J Crohns Colitis
; 5(2): 129-38, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21453882